ab21057 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab21057 は 9 報の論文で使用されています。

  • Xu S  et al. ANRIL lncRNA triggers efficient therapeutic efficacy by reprogramming the aberrant INK4-hub in melanoma. Cancer Lett N/A:N/A (2016). WB ; Human . PubMed: 27461581
  • Anand U  et al. Mechanisms underlying clinical efficacy of Angiotensin II type 2 receptor (AT2R) antagonist EMA401 in neuropathic pain: clinical tissue and in vitro studies. Mol Pain 11:38 (2015). ICC/IF . PubMed: 26111701
  • Handley MT  et al. Warburg Micro syndrome is caused by RAB18 deficiency or dysregulation. Open Biol 5:150047 (2015). PubMed: 26063829
  • Singer BB  et al. Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses. PLoS One 9:e94106 (2014). WB ; Human . PubMed: 24743304
  • Gammons MV  et al. Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma. Br J Cancer 111:477-85 (2014). PubMed: 25010863
  • Gammons MV  et al. Topical antiangiogenic SRPK1 inhibitors reduce choroidal neovascularization in rodent models of exudative AMD. Invest Ophthalmol Vis Sci 54:6052-62 (2013). PubMed: 23887803
  • Scarlett UK  et al. Ovarian cancer progression is controlled by phenotypic changes in dendritic cells. J Exp Med 209:495-506 (2012). WB ; Human . PubMed: 22351930
  • Stingele S  et al. Global analysis of genome, transcriptome and proteome reveals the response to aneuploidy in human cells. Mol Syst Biol 8:608 (2012). PubMed: 22968442
  • Dai J  et al. Studies of haspin-depleted cells reveal that spindle-pole integrity in mitosis requires chromosome cohesion. J Cell Sci 122:4168-76 (2009). ICC/IF ; Human . PubMed: 19910498

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"